BigBear.ai vs. Cerebras Systems: Which Tech Stock Is a Better Buy in 2026?

Cerebras Systems is favored over BigBear.ai based on 2025 revenue growth of 76% to nearly $510 million, net income of $238 million and a roughly 47% net margin, versus BigBear's revenue decline to nearly $128 million and $294 million net loss. Cerebras reported Q2 2026 revenue growth of 74% year over year and expects core revenue to more than triple in 2027, although its 81.6x P/S and 148.1x forward P/E imply a demanding valuation. BigBear's Q2 revenue rose 13% year over year and backlog increased 9%, but customer concentration, negative $73 million free cash flow, accounting-related class-action litigation and inconsistent growth make it a more speculative defense-AI investment.

Analysis

The relevant divergence is not simply software versus hardware: CBRS is being valued as a scarce alternative-compute platform, while its cash conversion suggests the economics may still resemble a capital-intensive systems vendor. If inference-service growth is real, recurring utilization can improve gross-margin durability and support the premium multiple; if growth remains dominated by large system shipments, working-capital and manufacturing demands can force dilution despite reported profitability. The key 1-3 month catalyst is customer-concentration disclosure, bookings conversion, and evidence that receivables/inventory are not absorbing incremental revenue.

BBAI's balance-sheet liquidity does not resolve its financing risk because persistent cash burn, litigation costs, and volatile contract timing can erode that cushion before operating scale arrives. Defense-autonomy spending is a multi-year tailwind, but incumbent primes—PLTR, LMT, NOC, RTX and LDOS—can bundle AI capabilities into existing programs, limiting BBAI's pricing power and making new-contract counts less important than funded backlog, recompete win rates, and gross-margin progression. Near term, accounting and filing developments can dominate fundamentals and make the shares structurally unsuitable for unhedged long exposure.

Consensus appears to treat CBRS's high revenue growth as validation of a differentiated challenge to NVDA. The more consequential test is whether customers adopt its architecture broadly enough to overcome CUDA/software lock-in and whether supply commitments create negative operating leverage if AI capex normalizes. At an extreme sales multiple, even continued growth can produce downside if guidance merely decelerates rather than misses; the risk/reward is better expressed relative to incumbent AI compute exposure than as an outright momentum long.

Over 6-18 months, government AI procurement could favor integrated contractors and data-platform vendors over point-solution vendors, while AI infrastructure spending increasingly rewards suppliers with recurring software, networking, and power exposure. This creates a plausible barbell: retain selective CBRS upside only with a hedge against broad AI-hardware multiple compression, while avoiding BBAI until cash burn and customer concentration demonstrably improve.

Key Decisions for Investors

• Do not initiate an outright BBAI long before the next filing/litigation update. Reassess only if quarterly operating cash burn materially narrows, funded backlog converts to revenue, and no single-customer exposure rises; a filing delay, adverse legal ruling, or renewed equity issuance falsifies any turnaround setup.
• For AI exposure over the next 1-3 months, use a relative-value position: long CBRS / short a matched-dollar AI-hardware basket or SMH, sized small. The thesis is company-specific execution versus sector-beta; exit if CBRS revenue guidance decelerates materially, FCF burn worsens, or receivables/inventory expand faster than sales.
• Prefer NVDA over CBRS for core compute exposure until CBRS demonstrates repeatable recurring inference revenue and improving cash conversion. CBRS can outperform on another upside guide, but its valuation leaves limited tolerance for a bookings or supply-chain miss; treat it as a tactical satellite, not a strategic allocation.
• Monitor PLTR, LDOS, LMT and RTX around defense-budget awards and autonomous-systems program announcements over 6-18 months. These incumbents offer a cleaner route to defense-AI spend; favor them versus BBAI if awards emphasize integration with existing mission systems rather than standalone decision-intelligence deployments.